IHG Pharmaco Limited

Novel Biomarker Test with Treatment, to Predict and Prevent Miscarriage and Adverse Birth Outcomes in Ethnically Diverse Patient Populations.

Collaborative R&D

Developing mouthswab patient friendly testing combined with determining African/Asian incidence of a biomarker to reduce risks of adverse birth outcomes using a novel pharmacogenomic test

Collaborative R&D

Feasibility of Manufacturing a Reproductive Biomarker Test and Scoping for NHS Adoption in Primary Care

Feasibility Studies

capillary electrophoresis

Vouchers